You’re in your mid-30s, juggling your career, relationships, and everyday responsibilities, when suddenly you’re waking up ...

According to the National Spine Health Foundation, about 100 million Americans suffer from chronic neck or back pain each ...

A child lies dying of cancer in a hospital in Ingwavuma, a remote part of KwaZulu-Natal. Social worker Taryn Bell tries to ...

Gabapentin use jumped quickly in Michigan after the drug was removed from the state's controlled substance schedule in 2024, a cross-sectional study showed. From 2023 through 2025, gabapentin ...

The American College of Physicians (ACP) has released a new clinical guideline recommending estrogen, alone or combined with progestogen, as the first-line treatment for women experiencing hot flashes ...

Fezolinetant (Veozah) was associated with statistically significant improvements in objective and patient-reported sleep ...

The American College of Physicians now recommends estrogen-based hormone therapy as the first-line treatment for menopausal ...

In an increasingly aging society plagued by chronic pain, gabapentin has become one of the most commonly prescribed medications in the United States and Europe. However, a recent study published on ...

A new case report details how rare sacral herpes zoster disrupted a patient's urinary function, highlighting diagnostic ...

Michigan’s removal of gabapentin from its controlled substance schedule in May 2024 was associated with an immediate increase of 4 prescriptions per 1000 Medicaid enrollees. The policy reversal ...

Gabapentin is one of the top prescribed medications in the U.S. and is often used off-label for chronic pain. In 2019, Michigan enacted legislation to schedule gabapentin as a controlled substance but ...